David Renzi
2015
In 2015, David Renzi earned a total compensation of $1.6M as President and Chief Operating Officer at Carbylan Therapeutics, a 205% increase compared to previous year.
Compensation breakdown
| Bonus | $140,063 |
|---|---|
| Option Awards | $1,092,164 |
| Salary | $379,635 |
| Total | $1,611,862 |
Renzi received $1.1M in option awards, accounting for 68% of the total pay in 2015.
Renzi also received $140.1K in bonus and $379.6K in salary.
Rankings
In 2015, David Renzi's compensation ranked 5,627th out of 13,638 executives tracked by ExecPay. In other words, Renzi earned more than 58.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,627 out of 13,638 | 59th |
Division Manufacturing | 2,089 out of 5,187 | 60th |
Major group Chemicals And Allied Products | 756 out of 1,857 | 59th |
Industry group Drugs | 600 out of 1,531 | 61st |
Industry Pharmaceutical Preparations | 469 out of 1,179 | 60th |
Source: SEC filing on April 28, 2016.
Renzi's colleagues
We found two more compensation records of executives who worked with David Renzi at Carbylan Therapeutics in 2015.